help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JANSEN, D. F.
Right arrow Articles by POSTMA, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JANSEN, D. F.
Right arrow Articles by POSTMA, D. S.

Am. J. Respir. Crit. Care Med., Volume 160, Number 1, July 1999, 259-264

Smoking and Airway Hyperresponsiveness Especially in the Presence of Blood Eosinophilia Increase the Risk to Develop Respiratory Symptoms
A 25-year Follow-up Study in the General Adult Population

DÉSIRÉE F. JANSEN, JAN P. SCHOUTEN, JUDITH M. VONK, BERT RIJCKEN, WIM TIMENS, JAN KRAAN, SCOTT T. WEISS, and DIRKJE S. POSTMA

Departments of Epidemiology and Statistics, University of Groningen, Pathology and Pulmonology, University Hospital of Groningen, The Netherlands; and Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

Airway hyperresponsiveness (AHR) constitutes a risk for development of respiratory symptoms. We assessed whether blood eosinophilia (>=  275 eosinophils/µl), skin test positivity (sum score >=  3) and cigarette smoking (never, ex-smoker, 1-14 cig/d, 15-24 cig/d, >=  25 cig/d) at the first of two successive surveys are related to the development of respiratory symptoms (chronic cough or phlegm, bronchitis, persistent wheeze, dyspnea, and asthma) at the second survey, and whether these relations are the same in subjects with (PC10 =< 8 mg/ml histamine) and without AHR. We analyzed data of the longitudinal Vlagtwedde-Vlaardingen Study (1965 to 1990) using logistic regression analyses with paired observations, taking multiple measurements within a person into account. In total, 995 men and 792 women contributed 4,403 paired observations. Eosinophilia in hyperresponsive subjects significantly increased the risk to develop one or more respiratory symptoms (odds ratio [OR] = 3.67, 95% confidence interval [CI] = 1.79 to 7.52), wheeze (OR = 5.06, 95% CI = 2.11 to 12.13), and dyspnea (OR = 2.73, 95% CI = 1.13 to 6.60), independent of smoking, age, sex, area of residence, and time between two successive surveys. Smoking at the first of two successive surveys increased the risk to develop symptoms in a dose-dependent relation. Subjects with positive skin tests in the past were less likely to develop one or more respiratory symptoms (OR = 0.64, 95% CI = 0.46 to 0.88) and chronic phlegm (OR = 0.65, 95% CI = 0.42 to 1.00), independent of AHR. This longitudinal study in the general adult population shows that cigarette smoking and hyperresponsive subjects are at increased risk to develop respiratory symptoms, and especially so when eosinophilia is present in hyperresponsive persons.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. W. Gerbase, C. Schindler, J.-P. Zellweger, N. Kunzli, S. H. Downs, O. Brandli, J. Schwartz, M. Frey, L. Burdet, T. Rochat, et al.
Respiratory Effects of Environmental Tobacco Exposure Are Enhanced by Bronchial Hyperreactivity
Am. J. Respir. Crit. Care Med., November 15, 2006; 174(10): 1125 - 1131.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A H Morice, L McGarvey, I Pavord, and on behalf of the British Thoracic Society Cough Gu
Recommendations for the management of cough in adults
Thorax, September 1, 2006; 61(suppl_1): i1 - i24.
[Full Text] [PDF]


Home page
Eur Respir JHome page
L. Watson, J. P. Schouten, C-G. Lofdahl, N. B. Pride, L. A. Laitinen, D. S. Postma, and on behalf of the European Respiratory Society Stud
Predictors of COPD symptoms: does the sex of the patient matter?
Eur. Respir. J., August 1, 2006; 28(2): 311 - 318.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. S. Postma and H. M. Boezen
Rationale for the Dutch Hypothesis: Allergy and Airway Hyperresponsiveness as Genetic Factors and Their Interaction With Environment in the Development of Asthma and COPD
Chest, August 1, 2004; 126(2_suppl_1): 96S - 104S.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S.T. Weiss, D.L. DeMeo, and D.S. Postma
COPD: problems in diagnosis and measurement
Eur. Respir. J., June 1, 2003; 21(41_suppl): 4S - 12s.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. P. Jones, L. M. Hodge, K. Fujihashi, H. Kiyono, J. R. McGhee, and J. W. Simecka
The Pulmonary Environment Promotes Th2 Cell Responses After Nasal-Pulmonary Immunization with Antigen Alone, but Th1 Responses Are Induced During Instances of Intense Immune Stimulation
J. Immunol., October 15, 2001; 167(8): 4518 - 4526.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
N.S. Godtfredsen, P. Lange, E. Prescott, M. Osler, and J. Vestbo
Changes in smoking habits and risk of asthma: a longitudinal population based study
Eur. Respir. J., September 1, 2001; 18(3): 549 - 554.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society
  CCM abstracts